Skip to content

Educational Eczema Video Intervention

Randomized Controlled Trial of an Educational Eczema Video

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03664271
Enrollment
168
Registered
2018-09-10
Start date
2025-01-31
Completion date
2026-12-31
Last updated
2023-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema

Keywords

atopic dermatitis, eczema

Brief summary

The objectives of this study are to increase families' understanding of eczema and improve eczema management in the primary care setting. The investigators plan to create an educational video for families providing general information about eczema as well as instructions about good skincare management and common treatments. The investigators will conduct a randomized controlled trial of the plan in the primary care clinic at Boston Children's Hospital. Specifically, the investigators aim to (1) decrease eczema severity (2) improve patient and family quality of life (QOL) and (3) increase parental knowledge about eczema and eczema management.

Interventions

BEHAVIORALin-clinic video intervention

Video with information about eczema and eczema treatment, to be watched in clinic and at home

BEHAVIORALat home video intervention

Video with information about eczema and eczema treatment, to be watched at home only

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Eligibility criteria include the following: * accompanying adult speaks English * patient has a history of eczema * patient is between the ages of 1 month and 16 years * accompanying adult is a primary caregiver * child is not in foster care * accompanying adult is 18 years old or older.

Exclusion criteria

* accompanying adult does not speak English * accompanying adult is not the primary caregiver * accompanying adult is not 18 years old or older * patient is in foster care

Design outcomes

Primary

MeasureTime frameDescription
change in eczema severity3 month follow-upeczema severity as measured by the Patient Oriented Eczema Measure (0-28 range, higher score=worse eczema severity)

Secondary

MeasureTime frameDescription
change in infant quality of life3 month follow-upinfant quality of life as measured by the IDQOL (Infant's Dermatitis Quality of Life Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children \<4 years of age.
change in family quality of life3 month follow-upfamily quality of life as measured by the DFI (Dermatitis Family Impact Questionnaire), 0-30 scale with higher score reflecting worse quality of life
change in caregiver knowledge3 month follow-upchange in caregiver knowledge pre-post as assessed by a questionnaire. This is not a standardized tool, but rather a series of 22 questions about caregiver comfort and understanding of eczema. Some responses use a likert scale format, while others are multiple choice questions. There are 8 multiple choice questions, each of which has one right answer. Those can be totaled to determine percentage correct.
change in child quality of life3 month follow-upchild quality of life as measured by the CDLQI (Children's Dermatology Life Quality Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children age 4-16.

Contacts

Primary ContactCorinna Rea, MD, MPH
corinna.rea@childrens.harvard.edu6173554188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026